Objective evaluation of liver consistency to estimate hepatic fibrosis and functional reserve for hepatectomy

Journal of the American College of Surgeons

Volumn 191, Issue 1, 2000, Pages 47-53

  Kusaka, Koji ^a   Harihara, Yasushi ^a   Torzilli, Guido ^a   Kubota, Keiichi ^a   Takayama, Tadatoshi ^a   Makuuchi, Masatoshi ^a   Mori, Masaya ^a   Omata, Sadao ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b NIHON UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; FUNCTIONAL ASSESSMENT; HUMAN; LIVER FIBROSIS; LIVER FUNCTION; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; FEASIBILITY STUDIES; FEMALE; FIBROSIS; HEPATECTOMY; HUMANS; LIVER; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; REGRESSION ANALYSIS;

EID: 0033935317     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(00)00309-4     Document Type: Article

References (26)

1. Yamanaka N, Okamoto E, Oriyama T, et al. A prediction scoring system to select the surgical treatment of liver cancer. Ann Surg 1994;219:342-346.
2. Torzilli G, Makuuchi M, Inoue K, et al. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and non-cirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 1999;134:984-992.
3. Infante-Rivard C, Esnaola S, Villeneave JP. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology 1987;7:660-664.
4. Kawasaki S, Imamura N, Kokudo N, et al. A comparison between antipyrine and aminopyrine blood clearances. Hepatogastroenterology 1992;39:344-346.
5. Moody FG, Rikkers LF, Aldrete JS. Estimation of the functional reserve of human liver. Ann Surg 1974;180:592-598.
6. Lindskov J. The quantitative liver function as measured by the galactose elimination capacity. II. Prognostic value and changes during disease in patients with cirrhosis. Acta Med Scand 1982; 212:303-308.
7. Desmet VJ, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-1520.
8. Omata S, Terunuma Y. New tactile sensor like the human hand and its applications. Sensors and Actuators 1992;35:9-15.
9. Omata S, Yoshida S, Constantinou CE, et al. New medical sensor for detecting compliance of living tissue and its applications. Technical Digest of the 12th Sensor Symposium 1994;245-248.
10. Macintosh EL, Gauthier T, Pettigrew NM, et al. Hepatic fibrosis as a predictor of hepatic regenerative activity after partial hepatectomy in the rat. Hepatology 1992;17:307-309.
11. Miyagawa S, Makuuchi M, Kawasaki S, et al. Criteria for safe hepatic resection. Am J Surg 1995;169:589-594.
12. Torres-Salinas M, Pares A, Caballeria J, et al. Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitis. Gastroenterology 1986;90:1241-1246.
13. Pares A, Deulofeu R, Gimenez A, et al. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Hepatology 1996;24:1399-1403.
14. Chevallier M, Guerret S, Chossegros P, et al. A histological semi-quantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies. Hepatology 1994;20:349-355.
15. Yamanaka N, Okamota E, Toyosaka A, et al. Consistency of human liver. J Surg Res 1985;39:192-198.
16. Nishizaki T, Matsumata T, Kamakura T, et al. Significance of intraoperative measurement of liver consistency prior to hepatic resection. Hepatogastroenterology 1995;42:5-8.
17. Ito K, Ramirez-Schon G, Shah PM, et al. Functioning hepatic cell mass and the hyperdynamic state in cirrhosis. Surg Gynecol Obstet 1988;167:180-186.
18. Fan ST, Wang QS, Lo CM, et al. Evaluation of indocyanine green retention and aminopyrine breath tests in patients with malignant biliary obstruction. Aust N Z J Surg 1994;64:759-762.
19. Vlavianos P, Polson RJ, Settin A, et al. Haemodynamic and pharmacokinetic study of intravenous fenoldopam in patients with hepatic cirrhosis. Br J Clin Pharmacol 1990;29:19-25.
20. Vinel JP, Caucanas JP, Cales P, et al. Effect of propranolol on metabolic activity of the liver in patients with alcoholic cirrhosis. J Hepatol 1988;7:186-192.
21. Ott P, Keiding S, Bass L. Intrinsic hepatic clearance of indocyanine green in the pig: dependence on plasma protein concentration. Eur J Clin Invest 1992;22:347-357.
22. Inaba R, Inaba M, Iwamura K. Light microscopic and electron microscopic study on morphologic features resulting in the delay of ICG elimination in diabetic and non-diabetic fatty liver. Tokai J Exp Clin Med 1984;9:207-216.
23. Shimada M, Matsumata T, Adachi E, et al. Estimation of degree of liver cirrhosis using a fibrosis score: a multivariate analysis of clinical parameters and resected specimens. Hepatogastroenterology 1994;41:177-180.
24. Kajiwara E, Akagi K, Azuma K, et al. Evidence for an immunological pathogenesis of thrombocytopenia in chronic liver disease. Am J Gastroenterol 1995;90:962-966.
25. Lo CM, Lai ECS, Liu CL, et al. Laparoscopy and laparoscopic ultrasonography avoid exploratory laparotomy in patients with hepatocellular carcinoma. Ann Surg 1998;227:527-532.
26. Ohtsuka T, Furuse A, Kohno T, et al. Application of a new tactile sensor to thoracoscopic surgery: experimental and clinical study. Ann Thorac Surg 1995;60:610-614.